Incyte (INCY) Accumulated Expenses (2010 - 2026)

Incyte (INCY) posted Accumulated Expenses of $124.9 million for Q1 2026, down 87.89% on a QoQ basis from $1.0 billion in Q4 2025, and up 21.49% year-over-year from $102.8 million in Q1 2025.

Incyte (INCY) Accumulated Expenses (2010 - 2026) Analysis & Trends

Incyte's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $124.9 million for Q1 2026.

  • Quarterly Accumulated Expenses rose 21.49% year-over-year to $124.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124.9 million (up 21.49% YoY) and the FY2025 annual result came in at $1.0 billion, up 446.7% from the prior year.
  • Accumulated Expenses was $124.9 million for Q1 2026 at Incyte, down from $1.0 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.1 billion in Q1 2024 and bottomed at $9.0 million in Q2 2022.
  • A 5-year average of $441.4 million and a median of $168.2 million in 2025 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses jumped 5136.59% — and 2025, when it sank 90.67%.
  • Incyte's Accumulated Expenses stood at $701.1 million in 2022, then plunged by 78.13% to $153.3 million in 2023, then grew by 23.04% to $188.7 million in 2024, then soared by 446.7% to $1.0 billion in 2025, then sank by 87.89% to $124.9 million in 2026.
  • Business Quant data shows INCY's Accumulated Expenses at $124.9 million in Q1 2026, $1.0 billion in Q4 2025, and $168.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 124.92 Mn
Dec 31, 2025 1.03 Bn
Sep 30, 2025 168.25 Mn
Jun 30, 2025 857.09 Mn
Mar 31, 2025 102.82 Mn
Dec 31, 2024 188.68 Mn
Sep 30, 2024 150.72 Mn
Jun 30, 2024 1.03 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 153.35 Mn
Sep 30, 2023 820.61 Mn
Jun 30, 2023 111.71 Mn
Mar 31, 2023 825.44 Mn
Dec 31, 2022 701.05 Mn
Sep 30, 2022 106.31 Mn
Jun 30, 2022 8.95 Mn
Mar 31, 2022 15.76 Mn
Dec 31, 2021 108.96 Mn
Sep 30, 2021 23.89 Mn
Jun 30, 2021 82.76 Mn